Last reviewed · How we verify
docetaxel, nedaplatin, and fluorouracil — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
docetaxel, nedaplatin, and fluorouracil (docetaxel, nedaplatin, and fluorouracil) — Sun Yat-sen University.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| docetaxel, nedaplatin, and fluorouracil TARGET | docetaxel, nedaplatin, and fluorouracil | Sun Yat-sen University | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- docetaxel, nedaplatin, and fluorouracil CI watch — RSS
- docetaxel, nedaplatin, and fluorouracil CI watch — Atom
- docetaxel, nedaplatin, and fluorouracil CI watch — JSON
- docetaxel, nedaplatin, and fluorouracil alone — RSS
Cite this brief
Drug Landscape (2026). docetaxel, nedaplatin, and fluorouracil — Competitive Intelligence Brief. https://druglandscape.com/ci/docetaxel-nedaplatin-and-fluorouracil. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab